BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Dow
Deloitte
Boehringer Ingelheim
Novartis
Cantor Fitzgerald
Mallinckrodt
Fish and Richardson
Chubb

Generated: January 23, 2018

DrugPatentWatch Database Preview

Orphenadrine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for orphenadrine citrate and what is the scope of orphenadrine citrate freedom to operate?

Orphenadrine citrate
is the generic ingredient in two branded drugs marketed by Teligent, Akorn, Sagent Pharms, Watson Labs, West-ward Pharms Int, Medicis, Ascot, Gavis Pharms, Impax Pharms, Invagen Pharms, Sandoz, and Tedor Pharma Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for orphenadrine citrate. Thirty-two suppliers are listed for this compound.
Pharmacology for orphenadrine citrate

US Patents and Regulatory Information for orphenadrine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 084779-001 Mar 15, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 040484-001 May 24, 2006 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 040463-001 Mar 4, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis NORFLEX orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 012157-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tedor Pharma Inc ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040249-001 Jan 29, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 087062-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 084303-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040284-001 Jun 19, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ascot ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 088067-001 Apr 6, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent NORFLEX orphenadrine citrate INJECTABLE;INJECTION 013055-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Express Scripts
Accenture
Citi
Mallinckrodt
Queensland Health
Daiichi Sankyo
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot